Illumina Inc has a consensus price target of $182.35 based on the ratings of 26 analysts. The high is $365 issued by Barclays on August 6, 2021. The low is $100 issued by Barclays on April 10, 2024. The 3 most-recent analyst ratings were released by Stephens & Co., Citigroup, and RBC Capital on July 10, 2024, July 10, 2024, and July 1, 2024, respectively. With an average price target of $184 between Stephens & Co., Citigroup, and RBC Capital, there's an implied 60.42% upside for Illumina Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
07/10/2024 | Buy Now | 48.21% | Stephens & Co. | Mason Carrico | $170 → $170 | Reiterates | Overweight → Overweight | Get Alert |
07/10/2024 | Buy Now | 22.06% | Citigroup | Patrick Donnelly | → $140 | Upgrade | Neutral → Buy | Get Alert |
07/01/2024 | Buy Now | 110.99% | RBC Capital | Conor McNamara | $249 → $242 | Maintains | Outperform | Get Alert |
06/11/2024 | Buy Now | 52.57% | Evercore ISI Group | Vijay Kumar | $195 → $175 | Maintains | Outperform | Get Alert |
06/06/2024 | Buy Now | 6.36% | TD Cowen | Dan Brennan | $140 → $122 | Maintains | Hold | Get Alert |
06/03/2024 | Buy Now | 0.26% | Jefferies | Tycho Peterson | → $115 | Assumes | → Hold | Get Alert |
05/07/2024 | Buy Now | 48.21% | Stephens & Co. | Mason Carrico | → $170 | Reiterates | Overweight → Overweight | Get Alert |
05/06/2024 | Buy Now | 53.44% | Scotiabank | Sung Ji Nam | $185 → $176 | Maintains | Sector Outperform | Get Alert |
05/03/2024 | Buy Now | 11.6% | Baird | Catherine Ramsey | $125 → $128 | Maintains | Neutral | Get Alert |
04/10/2024 | Buy Now | 48.21% | Stephens & Co. | Mason Carrico | → $170 | Reiterates | Overweight → Overweight | Get Alert |
04/10/2024 | Buy Now | -12.82% | Barclays | Luke Sergott | $85 → $100 | Maintains | Underweight | Get Alert |
04/09/2024 | Buy Now | 120.58% | RBC Capital | Conor McNamara | → $253 | Reiterates | Outperform → Outperform | Get Alert |
03/20/2024 | Buy Now | — | OTR Global | — | — | Downgrade | Positive → Mixed | Get Alert |
02/14/2024 | Buy Now | 48.21% | Stephens & Co. | Mason Carrico | → $170 | Reiterates | Overweight → Overweight | Get Alert |
02/09/2024 | Buy Now | 124.93% | RBC Capital | Conor McNamara | → $258 | Reiterates | Outperform → Outperform | Get Alert |
01/25/2024 | Buy Now | -30.25% | Barclays | Luke Sergott | $50 → $80 | Maintains | Underweight | Get Alert |
01/04/2024 | Buy Now | — | TD Cowen | Dan Brennan | — | Downgrade | Outperform → Market Perform | Get Alert |
12/19/2023 | Buy Now | 124.93% | RBC Capital | Conor McNamara | $260 → $258 | Maintains | Outperform | Get Alert |
12/19/2023 | Buy Now | — | Scotiabank | Sung Ji Nam | — | Upgrade | Sector Perform → Sector Outperform | Get Alert |
12/18/2023 | Buy Now | — | Scotiabank | Sung Ji Nam | — | Upgrade | Sector Perform → Sector Outperform | Get Alert |
12/14/2023 | Buy Now | 35.14% | Guggenheim | Subbu Nambi | → $155 | Initiates | → Buy | Get Alert |
12/14/2023 | Buy Now | 48.21% | Stephens & Co. | Mason Carrico | → $170 | Initiates | → Overweight | Get Alert |
12/13/2023 | Buy Now | — | Wolfe Research | Doug Schenkel | — | Initiates | → Outperform | Get Alert |
12/12/2023 | Buy Now | -12.82% | B of A Securities | Derik De Bruin | $140 → $100 | Downgrade | Neutral → Underperform | Get Alert |
12/11/2023 | Buy Now | 4.62% | Citigroup | Patrick Donnelly | $85 → $120 | Upgrade | Sell → Neutral | Get Alert |
11/13/2023 | Buy Now | 65.65% | Piper Sandler | David Westenberg | $200 → $190 | Maintains | Overweight | Get Alert |
11/10/2023 | Buy Now | 4.62% | Canaccord Genuity | Kyle Mikson | $210 → $120 | Downgrade | Buy → Hold | Get Alert |
10/16/2023 | Buy Now | 74.37% | Piper Sandler | David Westenberg | $275 → $200 | Maintains | Overweight | Get Alert |
10/12/2023 | Buy Now | 74.37% | Stifel | Daniel Arias | → $200 | Reiterates | Buy → Buy | Get Alert |
09/29/2023 | Buy Now | 74.37% | Stifel | Daniel Arias | $225 → $200 | Maintains | Buy | Get Alert |
09/29/2023 | Buy Now | -12.82% | Barclays | Luke Sergott | $150 → $100 | Maintains | Underweight | Get Alert |
09/28/2023 | Buy Now | -3.23% | Bernstein | Eve Burstein | → $111 | Initiates | → Underperform | Get Alert |
09/01/2023 | Buy Now | 109.24% | Evercore ISI Group | Vijay Kumar | → $240 | Reiterates | Outperform → Outperform | Get Alert |
08/16/2023 | Buy Now | 148.47% | Canaccord Genuity | Kyle Mikson | $300 → $285 | Maintains | Buy | Get Alert |
08/15/2023 | Buy Now | 139.76% | Piper Sandler | David Westenberg | $290 → $275 | Maintains | Overweight | Get Alert |
08/14/2023 | Buy Now | 104.88% | HSBC | Shubhangi Gupta | $270 → $235 | Maintains | Buy | Get Alert |
08/10/2023 | Buy Now | 65.65% | JP Morgan | Julia Qin | $235 → $190 | Maintains | Neutral | Get Alert |
08/10/2023 | Buy Now | 30.78% | Citigroup | Patrick Donnelly | $180 → $150 | Maintains | Sell | Get Alert |
08/10/2023 | Buy Now | 96.16% | Stifel | Daniel Arias | $265 → $225 | Maintains | Buy | Get Alert |
08/10/2023 | Buy Now | 109.24% | Evercore ISI Group | Vijay Kumar | $235 → $240 | Maintains | Outperform | Get Alert |
08/10/2023 | Buy Now | 74.37% | Credit Suisse | Dan Leonard | $225 → $200 | Maintains | Neutral | Get Alert |
07/06/2023 | Buy Now | 161.55% | Canaccord Genuity | Kyle Mikson | → $300 | Reiterates | Buy → Buy | Get Alert |
06/12/2023 | Buy Now | 161.55% | Canaccord Genuity | Kyle Mikson | → $300 | Reiterates | Buy → Buy | Get Alert |
04/26/2023 | Buy Now | 191.19% | RBC Capital | Conor McNamara | $337 → $334 | Maintains | Outperform | Get Alert |
04/26/2023 | Buy Now | 131.04% | Stifel | Daniel Arias | $235 → $265 | Maintains | Buy | Get Alert |
04/26/2023 | Buy Now | 99.65% | Baird | Catherine Ramsey | $224 → $229 | Maintains | Neutral | Get Alert |
03/15/2023 | Buy Now | 161.55% | RBC Capital | Conor McNamara | $303 → $300 | Maintains | Outperform | Get Alert |
02/14/2023 | Buy Now | 109.24% | UBS | John Sourbeer | $255 → $240 | Maintains | Neutral | Get Alert |
02/08/2023 | Buy Now | 152.83% | Piper Sandler | David Westenberg | → $290 | Maintains | Overweight | Get Alert |
02/08/2023 | Buy Now | 164.17% | RBC Capital | Conor McNamara | $284 → $303 | Maintains | Outperform | Get Alert |
02/08/2023 | Buy Now | 136.27% | JP Morgan | Julia Qin | $300 → $271 | Maintains | Neutral | Get Alert |
02/08/2023 | Buy Now | 30.78% | Barclays | Luke Sergott | $160 → $150 | Maintains | Underweight | Get Alert |
02/08/2023 | Buy Now | 117.96% | SVB Leerink | Puneet Souda | $249 → $250 | Maintains | Outperform | Get Alert |
01/25/2023 | Buy Now | — | Argus Research | Jasper Hellweg | — | Downgrade | Buy → Hold | Get Alert |
01/17/2023 | Buy Now | 161.55% | Canaccord Genuity | Kyle Mikson | $330 → $300 | Maintains | Buy | Get Alert |
01/05/2023 | Buy Now | 88.32% | Scotiabank | Sung Ji Nam | → $216 | Initiates | → Sector Perform | Get Alert |
12/20/2022 | Buy Now | — | OTR Global | — | — | Upgrade | Mixed → Positive | Get Alert |
12/12/2022 | Buy Now | 56.93% | Citigroup | Patrick Donnelly | $200 → $180 | Downgrade | Neutral → Sell | Get Alert |
12/07/2022 | Buy Now | 145.86% | RBC Capital | Conor McNamara | → $282 | Initiates | → Outperform | Get Alert |
11/14/2022 | Buy Now | 161.55% | Piper Sandler | David Westenberg | $320 → $300 | Maintains | Overweight | Get Alert |
11/07/2022 | Buy Now | 96.16% | Morgan Stanley | Tejas Savant | $240 → $225 | Maintains | Equal-Weight | Get Alert |
11/04/2022 | Buy Now | 96.16% | Credit Suisse | Dan Leonard | $230 → $225 | Maintains | Neutral | Get Alert |
10/04/2022 | Buy Now | 135.4% | SVB Leerink | Puneet Souda | $220 → $270 | Upgrade | Market Perform → Outperform | Get Alert |
09/30/2022 | Buy Now | 52.57% | Barclays | Luke Sergott | $130 → $175 | Maintains | Underweight | Get Alert |
09/28/2022 | Buy Now | 117.96% | Evercore ISI Group | Vijay Kumar | → $250 | Upgrade | In-Line → Outperform | Get Alert |
08/25/2022 | Buy Now | 100.52% | Credit Suisse | Dan Leonard | → $230 | Initiates | → Neutral | Get Alert |
08/17/2022 | Buy Now | 113.6% | UBS | Dan Brennan | $350 → $245 | Maintains | Neutral | Get Alert |
08/15/2022 | Buy Now | 109.24% | Morgan Stanley | Tejas Savant | $350 → $240 | Maintains | Equal-Weight | Get Alert |
08/12/2022 | Buy Now | 178.99% | Piper Sandler | David Westenberg | $360 → $320 | Maintains | Overweight | Get Alert |
08/12/2022 | Buy Now | 161.55% | Stifel | Daniel Arias | $480 → $300 | Maintains | Buy | Get Alert |
08/12/2022 | Buy Now | 91.8% | SVB Leerink | Puneet Souda | $225 → $220 | Maintains | Market Perform | Get Alert |
08/12/2022 | Buy Now | 74.37% | Citigroup | Patrick Donnelly | $220 → $200 | Maintains | Neutral | Get Alert |
07/14/2022 | Buy Now | 30.78% | Barclays | Luke Sergott | $350 → $150 | Downgrade | Equal-Weight → Underweight | Get Alert |
07/13/2022 | Buy Now | 30.78% | Barclays | Luke Sergott | $350 → $150 | Downgrade | Equal-Weight → Underweight | Get Alert |
07/08/2022 | Buy Now | 91.8% | Citigroup | Patrick Donnelly | $325 → $220 | Maintains | Neutral | Get Alert |
05/16/2022 | Buy Now | 213.86% | Piper Sandler | David Westenberg | $460 → $360 | Maintains | Overweight | Get Alert |
05/09/2022 | Buy Now | 205.14% | Morgan Stanley | Tejas Savant | $425 → $350 | Maintains | Equal-Weight | Get Alert |
05/06/2022 | Buy Now | 183.35% | Citigroup | Patrick Donnelly | $400 → $325 | Maintains | Neutral | Get Alert |
03/29/2022 | Buy Now | — | OTR Global | — | — | Upgrade | Mixed → Positive | Get Alert |
02/15/2022 | Buy Now | 301.05% | Piper Sandler | David Westenberg | $450 → $460 | Maintains | Overweight | Get Alert |
02/11/2022 | Buy Now | 248.74% | SVB Leerink | Puneet Souda | $430 → $400 | Maintains | Market Perform | Get Alert |
01/18/2022 | Buy Now | — | Stifel | Daniel Arias | — | Upgrade | Hold → Buy | Get Alert |
01/12/2022 | Buy Now | 248.74% | Barclays | Luke Sergott | $350 → $400 | Upgrade | Underweight → Equal-Weight | Get Alert |
01/11/2022 | Buy Now | — | Barclays | Luke Sergott | — | Upgrade | Underweight → Equal-Weight | Get Alert |
01/11/2022 | Buy Now | 274.89% | SVB Leerink | Puneet Souda | $420 → $430 | Maintains | Market Perform | Get Alert |
01/10/2022 | Buy Now | 205.14% | Barclays | Luke Sergott | $365 → $350 | Maintains | Underweight | Get Alert |
01/07/2022 | Buy Now | 240.02% | B of A Securities | Derik De Bruin | → $390 | Upgrade | Underperform → Neutral | Get Alert |
10/19/2021 | Buy Now | 266.17% | SVB Leerink | Puneet Souda | — | Maintains | Market Perform | Get Alert |
10/01/2021 | Buy Now | — | OTR Global | — | — | Downgrade | Positive → Mixed | Get Alert |
08/19/2021 | Buy Now | 270.53% | SVB Leerink | Puneet Souda | — | Downgrade | Outperform → Market Perform | Get Alert |
08/06/2021 | Buy Now | 218.22% | Barclays | Peter Lawson | — | Maintains | Underweight | Get Alert |
The latest price target for Illumina (NASDAQ:ILMN) was reported by Stephens & Co. on July 10, 2024. The analyst firm set a price target for $170.00 expecting ILMN to rise to within 12 months (a possible 48.21% upside). 41 analyst firms have reported ratings in the last year.
The latest analyst rating for Illumina (NASDAQ:ILMN) was provided by Stephens & Co., and Illumina reiterated their overweight rating.
The last upgrade for Illumina Inc happened on July 10, 2024 when Citigroup raised their price target to $140. Citigroup previously had a neutral for Illumina Inc.
The last downgrade for Illumina Inc happened on March 20, 2024 when OTR Global changed their price target from N/A to N/A for Illumina Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Illumina, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Illumina was filed on July 10, 2024 so you should expect the next rating to be made available sometime around July 10, 2025.
While ratings are subjective and will change, the latest Illumina (ILMN) rating was a reiterated with a price target of $170.00 to $170.00. The current price Illumina (ILMN) is trading at is $114.70, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.